Cancer Drug Preauthorization List Expanded in August


Starting Aug. 15, 2021, ConnectiCare and EmblemHealth will require preauthorization for additional oncology-related chemotherapeutic drugs and supportive agents when delivered in the physician’s office, outpatient hospital, or other ambulatory setting. See ConnectiCare’s Pharmacy Policies and EmblemHealth’s Frequently Asked Questions: EmblemHealth Oncology Drug Management to determine where to submit the preauthorization request.